AC Immune to Present at the Jefferies 2025 London Healthcare Conference
AC Immune to Present at the Jefferies 2025 London Healthcare Conference GlobeNewswire November 11, 2025 AC Immune to Present at the Jefferies 2025 London Healthcare Conference Lausanne, Switzerland, November 11, 2025 — AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today announced that Company Management will participate in […]